IM Cannabis (IMCC) Liabilities and Shareholders Equity (2019 - 2026)

IM Cannabis' Liabilities and Shareholders Equity history runs 8 years deep, the most recent figure standing at $17.3 million for Q1 2026.

• In Q1 2026, Liabilities and Shareholders Equity fell 44.81% year-over-year to $17.3 million; the TTM figure through Mar 2026 stood at $101.9 million (down 16.13% YoY), while the FY2025 annual figure was $22.8 million, down 20.49% from the prior year.
• Liabilities and Shareholders Equity was $17.3 million for Q1 2026 at IM Cannabis, down from $22.8 million in the prior quarter.
• In the past five years, Liabilities and Shareholders Equity ranged from a high of $221.9 million in Q1 2022 to a low of $17.3 million in Q1 2026.
• Historically, Liabilities and Shareholders Equity has averaged $57.5 million across 5 years, with a median of $32.7 million in 2024.
• The sharpest annual moves came in 2022 and 2023: Liabilities and Shareholders Equity jumped 68.93% in 2022, then slumped 81.07% in 2023.
• A 5-year view of Liabilities and Shareholders Equity shows it stood at $44.7 million in 2022, then fell by 19.79% to $35.9 million in 2023, then fell by 21.76% to $28.1 million in 2024, then fell by 18.88% to $22.8 million in 2025, then decreased by 24.06% to $17.3 million in 2026.
• The last three Liabilities and Shareholders Equity figures came in at $17.3 million (Q1 2026), $22.8 million (Q4 2025), and $32.2 million (Q3 2025), per Business Quant data.